
HER2 Evolution in Gastroesophageal Cancer: New Therapies and Optimized Outcomes
01/12/2025
0:00
27:15
Learn which HER2-targeted therapies are being evaluated for the first-line treatment of gastroesophageal adenocarcinoma.
Credit available for this activity expires: 11/27/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/her2-evolution-gastroesophageal-cancer-new-therapies-and-2025a1000x2t?ecd=bdc_podcast_libsyn_mscpedu
D'autres épisodes de "Keeping Current CME"



Ne ratez aucun épisode de “Keeping Current CME” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.







